journal
MENU ▼
Read by QxMD icon Read
search

P & T: a Peer-reviewed Journal for Formulary Management

journal
https://www.readbyqxmd.com/read/28250705/research-briefs
#1
(no author information available yet)
No abstract text is available yet for this article.
March 2017: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/28250704/american-college-of-rheumatology-association-of-rheumatology-health-professionals-annual-meeting
#2
Peter Sonnenreich, John Jesitus
We present sessions on establishing key clinical trial outcomes in psoriatic arthritis and on delaying the radiographic progression of ankylosing spondylitis.
March 2017: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/28250703/targeting-interleukin-5-in-patients-with-severe-eosinophilic-asthma-a-clinical-review
#3
Christine Lam, Kunal J Shah, Rupal Mansukhani
Interleukin-5 (IL-5) is known to play a major role in the growth, differentiation, recruitment, and activation of eosinophils. The authors review the efficacy and safety of two IL-5-targeting agents used in the treatment of eosinophilic asthma.
March 2017: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/28250702/an-evaluation-of-selected-indications-and-appropriateness-of-ampicillin-sulbactam-an-unrestricted-antimicrobial-at-a-single-center
#4
Dorothy McCoy, Rani Sebti, Arpi G Kuyumjian
BACKGROUND: With antimicrobial resistance on the rise and few new agents in development, it is important to exercise prudent judgment when utilizing antimicrobials. The Antimicrobial Stewardship Program (ASP) is responsible for facilitating the appropriate use of antimicrobials at the institution. Restricted antimicrobials and select additional antimicrobials are monitored by the ASP team to determine if the indications chosen by the ordering prescribers correspond to and are appropriate for the patients' infections...
March 2017: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/28250701/medicinal-cannabis-history-pharmacology-and-implications-for-the-acute-care-setting
#5
Mary Barna Bridgeman, Daniel T Abazia
The authors review the historical use of medicinal cannabis and discuss the agent's pharmacology and pharmacokinetics, select evidence on medicinal uses, and the implications of evolving regulations on the acute care hospital setting.
March 2017: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/28250700/fda-revisits-rules-on-drug-and-device-communication-will-the-agency-relax-existing-industry-opposed-restrictions
#6
Stephen Barlas
The Food and Drug Administration issued draft guidances in January that tackled health care economic information and product labeling. Do these publications indicate a potential shift in on- and off-label policies for drugs and devices?
March 2017: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/28250699/rolapitant-varubi-a-substance-p-neurokinin-1-receptor-antagonist-for-the-prevention-of-chemotherapy-induced-nausea-and-vomiting
#7
Tamara Goldberg, Brooke Fidler, Stephanie Cardinale
Rolapitant (Varubi) for the prevention of chemotherapy-induced nausea and vomiting.
March 2017: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/28250698/pharmaceutical-approval-update
#8
Mary Choy
Insulin degludec/liraglutide (Xultophy 100/3.6) for type-2 diabetes; rucaparib (Rubraca) for the treatment of deleterious BRCA mutation-associated ovarian cancer; and nusinersen (Spinraza) for the treatment of spinal muscular atrophy.
March 2017: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/28250697/drug-and-device-news
#9
(no author information available yet)
Approvals, new indications, regulatory activities, and more.
March 2017: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/28250696/concerns-still-percolate-around-compounding-new-fda-and-gao-reports-highlight-continuing-issues
#10
Stephen Barlas
New FDA and GAO reports highlight compounding issues.
March 2017: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/28250695/a-mislabeling-event-with-batched-drugs-the-unintended-consequences-of-practice-changes
#11
Matthew Grissinger
Practice changes cause the mislabeling of batched drugs.
March 2017: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/28163561/research-briefs
#12
(no author information available yet)
No abstract text is available yet for this article.
February 2017: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/28163560/american-society-of-hematology-annual-meeting-and-exposition
#13
Walter Alexander
Key sessions on pharmacotherapy clinical trials across a wide span of disease states, including leukemia, graft-versus-host disease, myelofibrosis, multiple myeloma, and sickle cell disease, are reviewed.
February 2017: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/28163559/new-schizophrenia-treatments-address-unmet-clinical-needs
#14
Chris Fellner
We present several novel drugs in development for enhancing cognition, treating negative symptoms, and providing improved options for treatment-resistant patients. Drug makers aim to enhance safety profiles and increase patient compliance to therapy.
February 2017: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/28163558/effect-of-intravenous-acetaminophen-on-post-anesthesia-care-unit-length-of-stay-opioid-consumption-pain-and-analgesic-drug-costs-after-ambulatory-surgery
#15
Moteb A Khobrani, James M Camamo, Asad E Patanwala
OBJECTIVES: The primary objective was to assess whether the use of intravenous acetaminophen (APAP) in the ambulatory surgery setting is associated with a decreased length of stay in the post-anesthesia care unit (PACU). The secondary outcomes evaluated were pain scores, opioid consumption, and total cost of analgesics used in the PACU. METHODS: This was a retrospective cohort study conducted in adult patients (18 years of age or older) who received an eye, ear, nose, or throat (EENT) procedure at an outpatient surgery center between January 2014 and January 2015...
February 2017: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/28163557/experts-provide-a-glimpse-of-the-new-post-sprint-era-of-hypertension
#16
Susan L Worley
In advance of the new guidelines being published this year, the author discusses treatment targets, diagnostics, and public policy with three hypertension experts.
February 2017: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/28163556/new-pharmacotherapies-in-chronic-lymphocytic-leukemia
#17
Jacqueline L Olin, Katherine Canupp, Morgan B Smith
The authors present the clinical outcomes and therapeutic application of newly approved pharmacotherapies for chronic lymphocytic leukemia and highlight emerging investigational therapeutic options.
February 2017: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/28163555/fda-flags-inconsistent-hospital-reporting-of-medical-device-problems-hazy-reporting-rules-beget-confusion
#18
Stephen Barlas
The National Evaluation System for Health Technology will be developed over the next five years to upgrade and improve the reporting of medical device adverse events. However, participants using the new system will incur significant capital costs.
February 2017: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/28163554/brivaracetam-briviact-a-novel-adjunctive-therapy-for-partial-onset-seizures
#19
Farbod Khaleghi, Eric C Nemec
Brivaracetam (Briviact): a novel adjunctive therapy for partial-onset seizures.
February 2017: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/28163553/pharmaceutical-approval-update
#20
Michele B Kaufman
Prasterone (Intrarosa) for the treatment of dyspareunia due to menopause; crisaborole (Eucrisa) for the topical treatment of atopic dermatitis; and tenofovir alafenamide (Vemlidy) for once-daily treatment of chronic hepatitis B virus infection.
February 2017: P & T: a Peer-reviewed Journal for Formulary Management
journal
journal
30579
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"